Pular para o conteúdo
Merck
Todas as fotos(1)

Documentos Principais

P2939000

Prilocaine

European Pharmacopoeia (EP) Reference Standard

Sinônimo(s):

(±)-2′-Methyl-2-(propylamino)propionanilide, N-(2-Methylphenyl)-2-(propylamino)propanamide

Faça loginpara ver os preços organizacionais e de contrato
Todas as fotos(1)

About This Item

Fórmula empírica (Notação de Hill):
C13H20N2O
Número CAS:
721-50-6
Peso molecular:
220.31
Código UNSPSC:
41116107
NACRES:
NA.24

grau

pharmaceutical primary standard

família API

prilocaine

fabricante/nome comercial

EDQM

aplicação(ões)

pharmaceutical (small molecule)

Formato

neat

temperatura de armazenamento

2-8°C

InChI

1S/C13H20N2O/c1-4-9-14-11(3)13(16)15-12-8-6-5-7-10(12)2/h5-8,11,14H,4,9H2,1-3H3,(H,15,16)

chave InChI

MVFGUOIZUNYYSO-UHFFFAOYSA-N

Procurando produtos similares? Visita Guia de comparação de produtos

Descrição geral

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Aplicação

Prilocaine EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Embalagem

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Outras notas

Sales restrictions may apply.

produto relacionado

Nº do produto
Descrição
Preços

1561019

Prilocaine Related Compound A, United States Pharmacopeia (USP) Reference Standard

P2939025

Prilocaine impurity E, European Pharmacopoeia (EP) Reference Standard

P2939060

Prilocaine hydrochloride, European Pharmacopoeia (EP) Reference Standard

Y0001408

Prilocaine impurity B, European Pharmacopoeia (EP) Reference Standard

1561008

Prilocaine hydrochloride, United States Pharmacopeia (USP) Reference Standard

1561020

Prilocaine Related Compound B, United States Pharmacopeia (USP) Reference Standard

1560990

Prilocaine, United States Pharmacopeia (USP) Reference Standard

Y0001681

Prilocaine for peak identification, European Pharmacopoeia (EP) Reference Standard

BP497

Prilocaine hydrochloride, British Pharmacopoeia (BP) Reference Standard

PHR3105

Prilocaine, pharmaceutical secondary standard, certified reference material

PHR3106

Prilocaine Hydrochloride, pharmaceutical secondary standard, certified reference material

PHR3107

Prilocaine Related Compound A, pharmaceutical secondary standard, certified reference material

Pictogramas

Exclamation mark
GHS07

Palavra indicadora

Warning

Frases de perigo

H302,H319

Declarações de precaução

P301 + P312 + P330 - P305 + P351 + P338

Classificações de perigo

Acute Tox. 4 Oral - Eye Irrit. 2

Código de classe de armazenamento

11 - Combustible Solids

Classe de risco de água (WGK)

WGK 3

Escolha uma das versões mais recentes:

Certificados de análise (COA)

Lot/Batch Number

Lamentamos, não temos COA para este produto disponíveis online no momento.

Se precisar de ajuda, entre em contato Atendimento ao cliente

Já possui este produto?

Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.

Visite a Biblioteca de Documentos

M Y Hyun et al.
Clinical and experimental dermatology, 40(2), 129-135 (2014-10-17)
Hyaluronic acid (HA) fillers and poly-L-lactic acid (PLA) fillers are frequently used to correct facial wrinkles. To compare the efficacy and safety of a novel injectable poly-L-lactic acid (PLA) filler and a well-studied biphasic HA filler for the treatment of
Elena I Gubanova et al.
Journal of drugs in dermatology : JDD, 14(3), 288-298 (2015-03-05)
In this evaluator-blind, placebo-controlled study, microinjections of stabilized hyaluronic acid (HA) gel for rejuvenation of aging hands were evaluated. Patients received three injections of 1.0 ml HA gel (20 mg/ml HA) in the dorsum of one hand and 1.0 ml
Murad Alam et al.
JAMA dermatology, 150(8), 844-849 (2014-06-13)
Neocollagenesis can be achieved using a dermal rolling needle device, thereby reducing the appearance of acne scars. To determine the efficacy of a needling device for treatment of acne scars. We performed a single-center, rater-blinded, balanced (1:1), split-face, placebo-controlled, parallel-group
Hee Jung Lee et al.
The Journal of dermatological treatment, 26(1), 73-77 (2014-02-12)
Intense focused ultrasound (IFUS) has been used successfully for skin tightening. To investigate the efficacy of IFUS in treating enlarged pores and to evaluate changes in skin elasticity and sebum production following IFUS. Twenty-two subjects with enlarged pores were randomized
Adam Rish
Journal of cosmetic dermatology, 13(4), 253-260 (2014-11-18)
A review of 242 facial treatments, in 86 different patients, with polyacrylamide gel (PAAG) was carried out by the author between 2003 and 2013. To evaluate by retrospective study the long-term outcomes of PAAG filling for facial contouring. To quantify
Exibir todos os documentos relacionados

Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.

Entre em contato com a assistência técnica